Ranbaxy Confirms 'Global' Deal Resolving Antitrust MDL
By Brian Dowling ( March 24, 2022, 5:50 PM EDT) -- Parties in a multidistrict lawsuit against Ranbaxy Pharmaceuticals told a Boston federal judge Thursday to release their precious month of trial time after confirming that the company reached a $485 million global settlement to resolve claims it manipulated the U.S. Food and Drug Administration's generic-drug approval process to ice out competitors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.